Efficacy of Stop GnRH-Agonist/Antagonist versus GnRH-Antagonist Protocols in <i>In Vitro</i> Fertilization Cycles of Patients with Polycystic Ovary Syndrome: A Pilot Randomized Controlled Trial.
The Stop GnRH-agonist/GnRH-antagonist protocol is a viable alternative for PCOS patients, offering comparable oocyte yields and safety profiles to the conventional GnRH antagonist protocol. Larger studies are needed to confirm these findings and evaluate long-term outcomes such as pregnancy and live birth rates (registration number: IRCT20180409039247N10).
Authors
- Rana Karimi (ORCID: https://orcid.org/0000-0003-0780-5648)
- Azadeh Tarafdari (ORCID: https://orcid.org/0000-0003-4591-9507)
- Mohadese Dashtkoohi (ORCID: https://orcid.org/0000-0003-3579-4181)
- Marjan Ghaemi
- Fatemeh Keikhah
- M Masoumi
- Maryam Bagheri
- Mohammad Amin Prasaei
Institutions
- Imam Khomeini Hospital (IR)
- Tehran University of Medical Sciences (IR)
Publication Details
- Journal
- PubMed
- Published
- 2026-01-05
- DOI
- https://doi.org/10.22074/ijfs.2025.2041275.1762
- Primary Topic
- Ovarian function and disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00